AGP Executive Report
Last update: 10 hours agoRegulation & Patient Safety: India’s drugs regulator is considering red warning labels for cough syrups, including a “not for children below 4 years” message and pictorial cues to curb misuse in young kids. Food Safety Crackdown: FSSAI has launched three adjudication cases against Nestlé India over alleged infant nutrition claims and biotin-related lab findings, while Maharashtra FDA suspended licences of Mumbai’s Olympia Coffee House and a Nair Hospital canteen after hygiene and storage violations. Dengue Vaccine Rollout: Takeda and Dr Reddy’s will promote and distribute QDENGA in India’s private market from 2027 for ages 4–60, after CDSCO approval in July 2026. Pharma Approvals Speed-Up: Government plans to ease BA-BE study norms for domestic generic drug approvals via prior intimation instead of waiting for clearance, and to tighten sterile drug licensing under central oversight. Mental Health in Schools: Uttar Pradesh is rolling out a Student Mental Health and Well-being Policy with support cells, counselling and referral pathways. Healthcare Business & Tech: Merck KGaA is expanding its Bengaluru life-science manufacturing hub, and Walgreens plans a Chennai tech centre expected to create 250+ jobs.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
